Graded daily on value C-, growth C+, profitability A, momentum B-, revisions C. Sector-relative, identical for every user.
Pro Analysis Available: Full unrolled post citations, institutional 13F filing matrix, and real-time sentiment alerts for $CL are available with SpikePanel Pro.
Key events, in time order
Addresses rising demand for fluoride-free, sensitivity-relief oral care
Board declares regular quarterly cash dividend; payable Nov 13 to holders of record Oct 20
Q2 North America weak on soft trends, competition, destocking; plans premium toothpaste and portfolio actions
S&P quarterly rebalance confirms removal; passive fund rebalancing may affect trading
Talks with Iran and shipping-route hints ease the oil squeeze, but Tehran says no direct U.S. talks are under way
Organic sales growth was led by emerging markets, up mid-single digits, driven by India, Brazil, Mexico and China.
Net sales +4.9%; organic +2.4% (incl. -0.4% from lower private label pet food); GAAP EPS -5%.
Q2 adj EPS $0.99 beat, revenue $5.36B in line; shares fell 2.5% as company reaffirmed FY guide amid weak North America demand
Related — this ticker is not the subject
The White House signals a temporary pause in military risk even as talks with Tehran and Gulf shipping tensions remain unresolved.
None yet
None yet
Cases AI-clustered from trusted X authors over 2 weeks; counts are distinct authors. Volume does not predict direction · Not investment advice
No comments yet.
Facts and opinions separated · All items sourced · Not investment advice
